A new paper by a well-respected research scientist has just been published today in an equally well-respected journal (PLoS ONE),
It’s really very simple. The high rate of mutation giving rise to too many different types of cancer cells in a growing tumor has made it nearly impossible for so-called “tailored” or “targeted” therapy to
